Entities / Company
SIGA Technologies.
American pharmaceutical
- Reports this week
- 1
- Active events
- 1
- Connections
- 53
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
Gone quiet
No new reports in 90+ days-
SIGA Technologies, led by CEO Diem Nguyen, was listed on the Nasdaq stock exchange.Some support4 reports
-
SIGA Technologies received an analyst upgrade from Weiss Ratings and trades on the Nasdaq stock exchange.Some support1 report
-
Siga Technologies stock underperformed the S&P 500 gain but led the Medical sector gain on July 25, 2025.Some support7 reports
-
SIGA Technologies received international approvals for its TPOXX smallpox treatment in Europe, the U.K., Canada, and Japan.Some support2 reports
-
SIGA Technologies received U.S. Government funding under the BARDA 19C Contract for deliveries to the Strategic National Stockpile.Well supported3 reports
No events began in the chosen period. Widen it, or reset.
Around SIGA Technologies this week
News at the entities that move SIGA Technologies most-
Nasdaq StructuralNextNRG, Inc. received an amendment supporting its regaining of Nasdaq listing compliance.Moves SIGA Technologies
-
FDA OperationalFDA oversees drug trials in the US and Israel for Clearmind Medicine Inc., which is listed on Nasdaq.Moves SIGA Technologies
-
Department of Health & Human Services StructuralChina's NBS reports declining fixed-asset investment while the Trump administration implements staffing cuts and proposes ending NASA missions.Moves SIGA Technologies
-
Europe Shared contextMayor Hou attended a launch event in Europe on November 10, 2026.Moves SIGA Technologies
Connections
The 6 strongest of 53, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Diem Nguyen Structural
Diem Nguyen serves as the Chief Executive Officer of SIGA Technologies.
-
Nasdaq Structural
SIGA Technologies is formally listed and trades on the Nasdaq stock exchange.
-
FDA Operational
SIGA Technologies relies on the FDA for market approval and submission processes for its products.
-
Department of Health & Human Services Structural
SIGA Technologies supplies products to the Department of Health & Human Services stockpile.
-
Incepta Pharmaceuticals Shared context
Both companies operate within the shared context of the Medical - Drugs industry sector.
-
Europe Shared context
SIGA Technologies is obtaining regulatory approvals and market authorizations for its products within Europe.
History
Events by the month they beganNovember 2026
1 eventAugust 2026
1 eventJune 2026
4 events- SIGA Technologies received an analyst upgrade from Weiss Ratings and trades on the Nasdaq stock exchange.
- Siga Technologies stock underperformed the S&P 500 gain but led the Medical sector gain on July 25, 2025.
- SIGA Technologies received international approvals for its TPOXX smallpox treatment in Europe, the U.K., Canada, and Japan.
- SIGA Technologies received U.S. Government funding under the BARDA 19C Contract for deliveries to the Strategic National Stockpile.